Atlas Trials

Prophylactic TCRaB+ and CD19+ Depleted Donor Lymphocyte Infusion After Allogeneic Stem Cell Transplant in High-Risk Patients With Hematologic Malignancies

Clinical trial NCT07285668 · RECRUITING

Trial details

NCT number
NCT07285668
Sponsor
University of Wisconsin, Madison
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Hematologic Malignancies
Start date
2026-02-26
Primary completion
2029-02-01
Enrollment
38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.